about
Effect of different breathing patterns in the same patient on stereotactic ablative body radiotherapy dosimetry for primary renal cell carcinoma: a case study.Ten-year results of quality assurance in radiotherapy chart round.The use of dual vacuum stabilization device to reduce kidney motion for stereotactic radiotherapy planning.An analysis of respiratory induced kidney motion on four-dimensional computed tomography and its implications for stereotactic kidney radiotherapy.Stereotactic radiotherapy for pulmonary oligometastases: a systematic review.Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer.A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma.18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experience.Abscopal effects of radiation therapy: a clinical review for the radiobiologist.Surgical and ablative therapies for the management of adrenal 'oligometastases' - A systematic review.Extracranial oligometastatic renal cell carcinoma: current management and future directions.Mobilization of viable tumor cells into the circulation during radiation therapy.Comment on "it is not appropriate to 'deform' dose along with deformable image registration in adaptive radiotherapy" [Med. Phys. 39, 6531-6533 (2012)].High-resolution imaging of pulmonary ventilation and perfusion with 68Ga-VQ respiratory gated (4-D) PET/CT.Validation of a 4D-PET maximum intensity projection for delineation of an internal target volume.Plan of the day selection for online image-guided adaptive post-prostatectomy radiotherapy.68Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends.Cost minimisation analysis: kilovoltage imaging with automated repositioning versus electronic portal imaging in image-guided radiotherapy for prostate cancer.Results of patient specific quality assurance for patients undergoing stereotactic ablative radiotherapy for lung lesions.Validating and improving CT ventilation imaging by correlating with ventilation 4D-PET/CT using 68Ga-labeled nanoparticles.Vacuum immobilisation reduces tumour excursion and minimises intrafraction error in a cohort study of stereotactic ablative body radiotherapy for pulmonary metastasesAbscopal Effects after Conventional and Stereotactic Lung Irradiation of Non–Small-Cell Lung CancerTROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK IIImplementation of a lung radiosurgery program: technical considerations and quality assurance in an Australian institutionThe effect of irregular breathing patterns on internal target volumes in four-dimensional CT and cone-beam CT images in the context of stereotactic lung radiotherapyConventional margins not sufficient for post-prostatectomy prostate bed coverage: an analysis of 477 cone-beam computed tomography scansThe Abscopal Effect of Stereotactic Radiotherapy and Immunotherapy: Fool's Gold or El Dorado?Systematic endobronchial ultrasound-guided transbronchial needle aspiration improves radiotherapy planning in non-small cell lung cancerMetastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy
P50
Q34666936-E512CBE5-D2EA-418C-BD2A-E572A3A81777Q34686896-6B8E64DB-73FE-4272-AE47-D7E0313C4CABQ35087413-892FA5A9-E53B-4A0F-8085-C9AE77743B2EQ37312076-23BD4348-2146-48CC-88E7-FC811B09ECE1Q37755949-5BFD1103-B8DE-4F15-9A70-A8A527839405Q37848781-04487BDD-0A0C-4383-AB33-D340B50169F9Q38056219-4F166E72-9E27-4F81-8E1F-4B6B7D874D48Q38113466-32C1689B-2725-4C40-9C61-DB26E26FFE3DQ38152541-B2402655-1636-4B48-945E-F22FD7BF32D6Q38208911-64631232-E804-4155-BBE1-E7226288471EQ38209605-E940A4AC-C04C-473B-9351-7BA5B4F7B1A2Q42237728-64F66D8F-59CC-4E5A-BAB2-B148B457D03AQ44485301-41139D28-4060-4352-98F1-40827980B5D8Q44518809-CF981C68-0DCE-4E61-84AD-87694B8ABE8BQ44684908-60EB6806-6E2F-4556-B7AF-B67C3A8297A6Q45248045-45B3A05B-7579-48C6-8ADA-F7FE29C24607Q47269407-484A8923-3CCA-4E8E-8FC3-5EC05AACE1F9Q47627768-E6D825FE-3697-404F-8B87-77B3E13AEDB9Q53083934-9568C3EB-45B0-4A3A-AB2F-CFDD03FDF032Q53084240-26F5ADD3-B4D4-40EE-B56F-DEB50F197957Q57758810-0F934DB7-40E5-4C15-A74D-AFBCC5BA5FC6Q57758819-7D289AA4-E267-4CB1-8EA6-95412971694DQ57795895-91118A9B-4FFD-4692-BEC7-32A267486BA5Q84375252-37E8272D-038D-463A-BFD5-3D8CF8A721ECQ86072919-2288AB5C-2C62-44C6-8169-3ADE81CC9B98Q87211281-732CAE55-EB12-41B4-981F-F198D37D6B6AQ90039281-01529901-1B95-44C2-B57D-DAB663F5BCFFQ92007476-5F49D4FF-B700-4B24-96C8-0C62766FFB2DQ92089172-AC86C82A-8083-46C2-B3EA-B19693E10382
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Shankar Siva
@ast
Shankar Siva
@en
Shankar Siva
@es
Shankar Siva
@nl
type
label
Shankar Siva
@ast
Shankar Siva
@en
Shankar Siva
@es
Shankar Siva
@nl
prefLabel
Shankar Siva
@ast
Shankar Siva
@en
Shankar Siva
@es
Shankar Siva
@nl
P106
P1153
24345410600
P31
P496
0000-0003-2840-0658